Strategic Alliance Partners
Advertisement
Advertisement
Trending on Urology Times
1
Adding darolutamide to ADT and radiation improves MFS in very high-risk localized prostate cancer
2
PROTEUS Substudy: Perioperative apalutamide plus ADT improves EFS vs surgery alone
3
Updated CAPItello-281 data show numerical OS benefit with capivasertib in PTEN-deficient mHSPC
4
Daniel Heng, MD, highlights final LITESPARK-011 results in advanced ccRCC
5






















































